[P-HP] Hepatitis

[P-HP-08] Development of HBV episomal DNA inhibitors derived from mutant lentivirus screening

*Fumihiko TAKEUCHI¹, Sotaro Ikeda¹, Yuta Tsukamoto^1,2, Ryota Ouda^1,3, Makoto Hijikata¹, Koichi Watashi⁴, Takaji Wakita⁴, Kazuaki Chayama⁵, Amane Kogure¹, Hiroki Kato^1,2, Takashi Fujita¹ (1. Institute for Frontier Life and Medical Sciences, Kyoto University, 2. Institute of Cardiovascular Immunology, University Hospital Bonn, 3. Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 4. National Institute of Infectious Diseases, 5. Graduate School of Biomedical & Health Sciences, Hiroshima University)